Jupiter Life Line Hospitals schedules analyst meeting for February 10, 2026 at Nuvama Conference

1 min read     Updated on 04 Feb 2026, 07:37 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Jupiter Life Line Hospitals Limited has scheduled an analyst and institutional investor meeting for February 10, 2026, from 2:00 pm to 5:00 pm at the Nuvama Conference in Mumbai. The company filed the regulatory disclosure on February 4, 2026, confirming that discussions will be based on publicly available documents with no unpublished price sensitive information to be shared.

31759671

*this image is generated using AI for illustrative purposes only.

Jupiter life line hospital Limited has announced its participation in an upcoming investor conference, providing stakeholders with an opportunity to engage directly with company officials. The healthcare company filed the requisite disclosure with stock exchanges on February 4, 2026, in compliance with regulatory requirements.

Meeting Details and Schedule

The investor engagement is scheduled as part of the Nuvama Conference, with specific arrangements outlined for interested participants.

Parameter: Details
Date: February 10, 2026
Time: 2:00 pm to 5:00 pm
Format: 1x1 / Group Meeting
Organizer: Nuvama Conference
Venue: Mumbai

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance and transparent communication practices. Jupiter Life Line Hospitals Limited confirmed that all discussions during the investor interactions will be based exclusively on publicly available documents. The company explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these meetings, ensuring adherence to securities regulations.

Accessibility and Documentation

To maintain transparency, the company announced that details of the investor meeting will be made available on its official website at www.jupiterhospital.com . This ensures broader accessibility for stakeholders who may wish to review the information shared during the conference.

Operational Flexibility

The company has noted that the scheduled meeting details may be subject to changes due to operational exigencies on the part of either the host organization or the company itself. This provision allows for necessary adjustments while maintaining the commitment to investor engagement.

The disclosure was signed by Suma Upparatti, Company Secretary & Compliance Officer, demonstrating proper corporate governance protocols in the announcement of this investor relations activity.

Historical Stock Returns for Jupiter Life Line Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%-0.66%+1.31%-13.45%-15.05%+17.58%
Jupiter Life Line Hospital
View Company Insights
View All News
like17
dislike

Jupiter Life Line Hospitals Q3FY26 Results: Revenue Grows 9.8% as Dombivli Hospital Ready for Launch

3 min read     Updated on 30 Jan 2026, 07:03 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Jupiter Life Line Hospitals delivered Q3FY26 consolidated revenue growth of 9.8% to ₹365.3 crores despite net profit declining to ₹42.5 crores due to Labor Code provisions. The company's major milestone includes completion of its 500-bed Dombivli hospital ahead of schedule with February 15 launch date, representing ₹425 crores investment and expected EBITDA breakeven by end of second year.

31325615

*this image is generated using AI for illustrative purposes only.

Jupiter Life Line Hospitals Limited has announced its Q3FY26 unaudited financial results, showing robust operational performance with significant growth in total income. The healthcare services provider released its quarterly results through regulatory filings and newspaper publications, demonstrating strong business momentum during the quarter ended December 31, 2025. The company also held its earnings conference call on February 02, 2026, providing detailed insights into operational performance and expansion plans.

Q3FY26 Financial Performance Overview

The company delivered strong financial performance across key metrics during Q3FY26. The Board of Directors approved these results at their meeting held on January 30, 2026, with the Audit Committee having reviewed the financial statements prior to approval.

Financial Metric Q3FY26 (Standalone) Q3FY25 (Standalone) Growth
Total Income from Operations ₹3,005.58 million ₹2,772.61 million +8.4%
Net Profit Before Tax ₹597.61 million ₹622.80 million -4.0%
Net Profit After Tax ₹442.79 million ₹493.07 million -10.2%
Basic EPS (₹10 each) ₹6.75 ₹7.52 -10.2%

Consolidated Results Show Strong Performance

Jupiter Life Line Hospitals' consolidated results for Q3FY26 demonstrate the company's expanded operational scale and business growth across its healthcare network. During the earnings call, management highlighted that consolidated total income stood at ₹365.3 crores, representing a 9.8% year-on-year increase.

Consolidated Metrics Q3FY26 Q3FY25 Nine Months FY26
Total Income ₹365.3 crores ₹332.6 crores ₹1,111.9 crores
EBITDA ₹83.4 crores ₹76.4 crores ₹254.0 crores
Net Profit After Tax ₹42.5 crores ₹52.3 crores ₹143.9 crores
EBITDA Margin 22.8% 23.0% 22.8%

Dombivli Hospital Launch and Expansion Plans

The company announced that its new 500-bed Dombivli hospital is ready for launch, with inauguration scheduled for February 15, 2026. The 750,000 square foot facility was completed ahead of schedule and on budget, representing a total capex of approximately ₹425 crores. The hospital will commence operations with 200 beds in Phase 1, ramping up capacity gradually as occupancy increases.

Project Details Information
Total Beds 500 beds
Phase 1 Operations 200 beds
Total Capex ₹425 crores
Construction Timeline 24 months
Expected EBITDA Breakeven End of Year 2

Management indicated that the new hospital will create an EBITDA drag on consolidated numbers for approximately two years before contributing financially. The Pune South project construction has commenced with ₹45 crores capex incurred so far, while the Mira Road project remains under regulatory approval.

Operational Metrics and Performance Indicators

The company maintained strong operational metrics across its hospital network during the nine-month period. The payer mix remained stable with insurance representing 55.7% of revenue, self-payers contributing 43.2%, and government schemes accounting for 1.1%.

Operational Metrics Nine Months FY26 Q3FY26
ARPOB ₹66,800 ₹68,000
Average Occupancy 61.9% 61.4%
ALOS 3.85 days -
Doctor Costs 20-25% of revenue -

The company's profit after tax was impacted by ₹6.4 crores due to exceptional one-time provision related to new Labor Code implementation, affecting overall profitability margins during the quarter.

Regulatory Compliance and Future Outlook

Jupiter Life Line Hospitals Limited has fulfilled its regulatory obligations under SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The company published its financial results in Financial Express and Pudhari Newspaper Marathi, ensuring transparency for stakeholders and investors. The earnings conference call transcript has been made available on stock exchanges and the company website at www.jupiterhospital.com .

Source: Earnings Conference Call Transcript

Historical Stock Returns for Jupiter Life Line Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%-0.66%+1.31%-13.45%-15.05%+17.58%
Jupiter Life Line Hospital
View Company Insights
View All News
like18
dislike

More News on Jupiter Life Line Hospital

1 Year Returns:-15.05%